TwitterLinkedin

Contact Us

  • News & Events
    • News
    • Webinars
    • Events
  • Resource Library
    • Thought Leadership
    • Fact Flyers
    • Case Studies
    • White Papers
    • Webinars
    • Infographics
    • Video & Animation
  • Careers
    • Working at PharmaLex
    • Your Application Process
    • Current Opportunities
  • Training
Top Bar
Search
PharmaLex Logo
MENUMENU
  • PharmaLex Logo
  • PharmaLex Logo
  • About UsAbout Us
    • About Us
    • Management Team
    • Our Milestones
    • Corporate Social Responsibility
    • What Our Clients Say About Us
  • Our Services
    • Discovery / Non-clinical

          • Go to Discovery / Non-clinical section >>

          • Strategy and Consulting

            • Development Strategy and Gap Analysis
            • Integrated Product Development
            • Market Access
            • Non-clinical Development Concept
              and Study Design
            • Scientific Advice
            • Scientific Due Diligence
            • Statistical Services
            • Toxicology Services
    • Clinical Development

          • Go to Clinical Development section >>

          • Strategy and Consulting

            • Clinical Program Development
            • Orphan Drug Designation
            • Pediatric Investigation Plan (PIP)
            • Scientific Advice
            • Statistical Services

          • Regulatory Affairs

            • Clinical Trial Applications
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Regulatory Operations

          • Pharmacovigilance

            • Clinical Trial Safety Support
            • Pharmacovigilance Consulting

          • Quality

            • GxP Services
            • IMP Management
            • Interim / Contract QA
            • Quality Management Systems
            • Tech Transfer / Scale-up
            • Vendor Management and Oversight
    • Authorization / Approval

          • Go to Authorization / Approval section >>

          • Strategy and Consulting

            • Market Access

          • Regulatory Affairs

            • CMC Services
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Marketing and Labeling Activities
            • Regulatory Operations
            • Scientific, Regulatory and Technical Writing
            • Statistical Services

          • Pharmacovigilance

            • EU QPPV / National QPPV
            • Pharmacovigilance Consulting

          • Quality

            • Commercialization Readiness
            • Commissioning, Qualification, and Validation (CQV)
            • GxP Services
            • Interim / Contract QA
            • PAI Readiness
    • Post-approval / Maintenance

          • Go to Post-approval / Maintenance section >>

          • Strategy and Consulting

            • Environmental Risk Assessment
            • Market Access

          • Regulatory Affairs

            • CMC Services
            • Global End-to-End Outsourcing
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Marketing and Labeling Activities
            • Mergers and Acquisitions (M&A) Transfers
            • Regulatory Operations
            • Toxicology Services

          • Pharmacovigilance

            • Audit and CAPA Management
            • EU QPPV / National QPPV
            • ICSR Management
            • Literature Screening
            • Pharmacovigilance Systems
            • Safety Writing (PSUR, RMP)
            • Signal Management

          • Quality

            • Commissioning, Qualification, and Validation (CQV)
            • Good Distribution Practice (GDP) Compliance
            • GxP Services
            • Interim / Contract QA
            • Quality Management Systems
            • Vendor Audit
            • Vendor Management and Oversight

          • Medical Affairs

            • Healthcare Compliance and Medical Approval
            • Medical Information
    • Program Management

          • Go to Program Management section >>

          • Program Management

            • Global End-to-End Outsourcing
            • Global Procedure Management
            • Integrated Product Development
            • Mergers and Acquisitions (M&A) Transfers
    • Featured Expertise

          • Industry Expertise

            • Biopharmaceuticals
            • Consulting
            • Consumer Healthcare
            • Generics
            • Herbal Medicines
            • Medicinal Products
            • MedTech Services
            • Pharmaceutical
            • Veterinary Drugs

          • Service Expertise

            • ATMP / Cell and Gene Therapy
            • Brexit
            • COVID-19 Support
            • Drug Re-purposing / Value-added Medicines
            • GxP Services
            • Market Access
            • Pharmacovigilance Consulting
            • Statistical Services
            • SMARTPHLEX - technology-enabled services
  • Global ReachGlobal Reach
  • Contact usContact us
  • News & Events
    • News
    • Webinars
    • Events
  • Resource Library
    • Thought Leadership
    • Fact Flyers
    • Case Studies
    • White Papers
    • Webinars
    • Infographics
    • Video & Animation
  • Careers
    • Working at PharmaLex
    • Your Application Process
    • Career Opportunities
  • Training
Home > Digital Health Questionnaire

Digital HealthDigital Health Questionnaire

Are you developing health-related software or smart apps? Do you know if your software or app will be classified as a medical device? And is your product ready to meet the requirements of the new EU Medical Device Regulation (MDR) effective in May 2021? Complete our short questionnaire to learn more and find out what help you will need.

To support you with MDR readiness, our proprietary SMARTMDR tool is in a simple yet comprehensive assessment of your product’s readiness.  Learn more here

Please reach out to us if you have any questions. Contact us at contact@pharmalex.com.

1Any software with a medical intended use could be regulated as a medical device. Have you already qualified your software as medical device?

2Have you already classified all your software and devices under the new 2021 Medical Device Regulation (MDR)?

3If your product is classified as class IIa or higher, have you identified an accredited Notified body (NB) under MDR

4Have you integrated a Quality Management System (QMS) in your company?

5Are you aware that most software will no longer be Class I under the MDR and will require a NB assessment unless the software is already on the market before May 2021, in which case it can continue unchanged on the market until 2025?

According to the answers provided you seem to have a strong knowledge on the new challenges and requirement of MDR 2017/745. If you would like to see how PharmaLex can deploy the full SMARTMDR engine, please reach out to contact@pharmalex.com to see how we can help.
Print

On the basis of this small sample of questions, there may be some gaps remaining in your compliance and we recommend that you seek further advice. Pharmalex can assist you by deploying the full SMARTMDR engine to give you a more complete picture of what needs to be done to remain compliant. on your Medical Device Regulatory journey, please reach out to contact@pharmalex.com to see how we can help.
Print

On the basis of this small sample of questions, we strongly recommend you take immediate actions to continue commercializing your products under a monitored process. PharmaLex can assist you by deploying the full SMARTMDR engine to give you a more complete picture of what needs to be done to remain compliant, please reach out to contact@pharmalex.com to see how we can help.
Print

Related News

medical devices digital health era
Medical Devices in the Digital Health Era
10th December 2020
medical device combination products brexit
BREXIT: Medical Device/Combination Products - Key changes
3rd September 2020
Biotech Atelier
Biotech Atelier
26th August 2020

Related Resources

Fact Flyers

  • Medical Devices for the Pharmaceutical Industry
  • Medical Device Regulations Transition Support
  • Medical Device Services

White Papers

  • The Medical Device Regulation – Readiness for May 2021
  • Software, AI and Medical Devices - What's Up?

Infographics

  • Medical Device Regulations

Related Services

  • GxP Services
  • Health Authority / Agency Interaction
  • MedTech Services
  • PAI Readiness
  • PDE and OEL Services
  • Quality Management Systems
  • Tech Transfer / Scale-up
  • Toxicology Services
  • Vendor Audit
  • Vendor Management and Oversight
  • Virtual Audits
USEFUL LINKS
  • Home
  • Contact us
  • Imprint
  • Data Protection
  • Terms and Conditions
RECENT TWEETS
Tweets by @PharmaLexGLOBAL
COVID-19 NEWSLETTER SIGN UP

SIGN UP NOW

WHAT OUR CLIENTS SAY

  • Our project team were very impressed with the quality of the research and the reports that you sent through. We didn’t need any convincing that your recommendations should be followed. It showed PharmaLex in a very positive light, and the Project Team are keen to work with you again.

    Leading European Specialist Pharma Company
    Head of Medical Writing and Publications
PharmaLex
©2021 PharmaLex GmbH. All rights reserved.

ISO9001:2015 LogoEnergie Audit Logo

#AskTheExpert #TogetherBEYONDCOVID19





    Select your state:

    .
    You can unsubscribe at any time at data.protection@pharmalex.com

    If you do not wish to receive any communication from us, you can unsubscribe at any time at. Click here to view our Privacy Policy.

    #TogetherBEYONDCOVID19

    We closely monitor developments and updates surrounding the current outbreak of Coronavirus Disease 2019 (COVID-19) from official sources including the World Health Organisation and are following the guidance and direction of the governments and the local authorities. We are taking this situation very seriously and our number one priority is the safety and business continuity for our customers and colleagues. As ever, we will do everything we can to ensure that services are delivered within the required time and the trusted quality PharmaLex is known for

      Please DO NOT send us event/conference information.
      We will not respond and these will be deleted immediately.





      Select your state:

      .
      You can unsubscribe at any time at       data.protection@pharmalex.com

      Click here to view our Privacy Policy.

      Privacy Policy

      This can be specific information about signing up to the newsletter.

      Pellentesque lobortis, tellus at ultrices ullamcorper, lectus tellus consectetur lectus, id consequat leo quam quis eros. Mauris pellentesque tortor a augue pellentesque ultricies. Phasellus sit amet suscipit orci, vel dapibus ligula. Maecenas at pellentesque lectus, sit amet tristique felis. Integer fringilla risus ac neque mollis, at imperdiet lacus sodales. In vehicula orci sed vulputate interdum. Nunc sagittis non nunc eget sollicitudin.

      Maecenas a mattis erat. Phasellus cursus erat non nisl pulvinar ultricies. Aenean id fringilla libero. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Morbi in ultrices elit. Suspendisse egestas hendrerit est. Integer pellentesque nisl ut justo tempus, nec suscipit dolor luctus. Cras vestibulum elementum tincidunt.

      In compliance with the Spanish Law 15/1999, of Protection of Personal Data and in accordance with regulations approved by the Spanish RD 994/1999 inform you that your data will be part of a file located in Friedrichsdorf (Germany), whose ownership belongs to Pharmalex Spain S.L.U. The purpose of these data is the insertion in a potential job selection process. Inform the user that at any time may exercise their right of access, rectification, and deletion of data through email curriculum@pharmalex.com or to this postal address Pharmalex Spain. Coso 103, 50001 Zaragoza, Spain.